Search Results - "Waldegger, L"

Systematic assessment of the quality of osteoporosis guidelines by Cranney, A, Waldegger, L, Graham, I D, Man-Son-Hing, M, Byszewski, A, Ooi, D S

“…Numerous agencies have developed clinical practice guidelines for the management of postmenopausal osteoporosis. The study objective was to conduct a…”
Get full text

VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis by Cranney, Ann, Tugwell, Peter, Zytaruk, Nicole, Robinson, Vivian, Weaver, Bruce, Shea, Beverley, Wells, George, Adachi, Jonathan, Waldegger, Lisa, Guyatt, Gordon

Get full text

Development and pilot testing of a decision aid for postmenopausal women with osteoporosis by Cranney, Ann, O’Connor, Annette M, Jacobsen, Mary J, Tugwell, Peter, Adachi, Jonathan D, Ooi, Daylily S, Waldegger, Lisa, Goldstein, Rose, Wells, George A

“…This study’s aim was to develop and pilot test an evidence-based decision aid for postmenopausal women with osteoporosis who are considering options to prevent…”
Get full text

Cost-effectiveness of hip protectors in institutional dwelling elderly by WALDEGGER, Lisa, CRANNEY, Ann, MAN-SON-HING, Malcolm, COYLE, Doug

“…To assess the effectiveness and cost-effectiveness of hip protectors in the prevention of hip fracture in an elderly population living in institutions…”
Get full text

Effect of Ha-ras on mitogen-induced Ca(2+)- and K(+)-fluxes by Grunicke, H, Maly, K, Meyer, M, Oberhuber, H, Bichler, I, Waldegger, L S, Woell, E, Lang, F

“…Transforming Ha-ras enhances the mitogen-induced activation of both the Ca(2+)-influx and the furosemide-sensitive Na+/K+/2Cl-cotransporter. Both systems…”
Get more information

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis by Cranney, A, Adachi, J D, Guyatt, G, Papaioannou, A, Robinson, V A, Shea, B J, Tugwell, P, Waldegger, L M, Weaver, B, Wells, G, Zytaruk, N

“…Postmenopausal osteoporosis results in an increased susceptibility to low-trauma fractures due to reduced bone volume and microarchitectural deterioration…”
Get more information

Risedronate for the prevention and treatment of postmenopausal osteoporosis by Cranney, A, Waldegger, L, Zytaruk, N, Shea, B, Weaver, B, Papaioannou, A, Robinson, V, Wells, G, Tugwell, P, Adachi, J D, Guyatt, G

“…Postmenopausal osteoporosis results in an increased susceptibility to low-trauma fractures due to reduced bone volume and microarchitectural deterioration…”
Get more information